We identified an error in Table 3 concerning the classification of tumor depth. In the original publication, tumor depth was denoted using the prefix “p”. To more accurately reflect our data, we have revised the tumor depth categories by replacing “p” with “pathological or clinical.” In order to ensure consistency throughout the article, we have also updated the Abstract accordingly. We apologize for any inconvenience this may have caused and would like to make the following corrections.
Before correction:
...In the non-ER group, MRGCs at the pseudo-fornix (n=6) had more frequent undifferentiated-type histology (4/6 vs. 0/6), deeper (≥pT1b2; 6/6 vs. 2/6) and nodal metastasis (3/6 vs. 0/6) than non-pseudo-fornix lesions (n=6).
After correction:
...In the non-ER group, MRGCs at the pseudo-fornix (n=6) had more frequent undifferentiated-type histology (4/6 vs. 0/6), deeper (≥T1b2; 6/6 vs. 2/6) and nodal metastasis (3/6 vs. 0/6) than non-pseudo-fornix lesions (n=6).
Before correction:
Table 3. Comparison of clinicopathological features between pseudo-fornix located MRGCs and non-pseudo-fornix located MRGCs of the non-ER group (n=12)
Values are presented as number (%) or median (range).
MRGC = metachronous remnant gastric cancer; ER = endoscopic resection.
After correction:
Table 3. Comparison of clinicopathological features between pseudo-fornix located MRGCs and non-pseudo-fornix located MRGCs of the non-ER group (n=12)
Values are presented as number (%) or median (range).
MRGC = metachronous remnant gastric cancer; ER = endoscopic resection.